IMS @ Flashcards
(131 cards)
Hyperthyroidism Symptoms
Hyperactive, sweating, lose weight, heat intolerance, palpitations, menstrual problems, hand tremors, goitre,
Periordenadema (swelling around eyes), proptosis (protrusion of the eyes) and paralysis of eye muscles can cause double vision
Diagnosis and treatment of hyperthyroidism
Static Test
Graves disease - thyroid peroxidase enzymes positive in 80% of cases and TSHR antibodies positive in 99% of cases!
Treatment - antithyroid drugs for 6-18months
Radioactive iodine - destroys thyroid gland, but not for pregnant, children, lactating women, urinary incontinent or those with active eye disease
Growth hormone defeciency symptoms
Children - failure of growth
Adults - tiredness, depression, often asymptomatic and requires no treatment
Diagnosis: Glucagon stimulation test - should raise GH as it stimulates its realease and Insulin stress test lowers BGL so should increase it
Treatment: Replace GH injections, but expensive
How do enzymes work?
1) Provide catalytically competent groups
2) Bind substrates in the right orientation
3) Stabilise transition substances
These all lower the activation energy of a reaction!
Active sites bind substrates via multiple weak interactions, e.g. Trypsin
Trypsin His57, Asp 102, Ser 195 (close together when folded)
Km
Describes the enzymes affinity to a substrate. High Km means a low affinity! Km = (k2 + k3 )/ k1
Km is the substrate concentration when Vmax = 1/2
If Km = [S] then V=Vmax/2
V=Vmax x [S]/([S]+Km)
Irreversible Inhibition
Covalent modification of active site
Iadoacetamide –> carboxymethylates cysteine side chains
Nerve agents e.g. Parathion, inhibits Achesterase and modifies serine residues
Competitive Reversible Inhibition
Enzyme binds to inhibitor or substrate but not both
High substrate overcomes inhibition
Vmax unchanged, Km Increased
Methotrexate competitively inhibits dihydrofolate needed for DNA/RNA synthesis
Non-competitive Inhibition
Enzyme binds to inhibitor and substrate as inhibitor doesn’t bind at active site
High substrate won’t overcome inhibition
Max decreased, Km stays the same
Alanine inhibits Pyruvate kinase
What do NADH, coA and Biotin carry
CO2
CoA carries acyl units, used with pantothenic acid (we must consume this acid)
Riboflavin defeciency
Ariboflavinosis
Niacin defeciency
Pellagra
Niacin acts as an electron donor to NADH
Thiamine defeciency
Beriberi
Vit C defeciency
Scurvy
Glucose-6-dehydrogenase defeciency
Commonest mutation, X-linked recessive
Enzyme is needed to produce large amounts of NADPH
Glucose –> Glucose 6 phosphate –> Pentose phophate pathway –> Ribose-5-phosphate which produces lots of NADP in the first step an important metabolic pathway to provide reducing power to erythrocytes
Mutation blocks NADP stops it being responsive to NADP levels
High incidence in malarial regions!
But causes primaquine-induced haemolytic anaemia!
Why do we need NADP?
NADPH refors glutathione (reduced), a scavenger molecule that reacts with free radicals
RBC’s have no mitochondria hence only make NADP via the glucose-6-deyhdrogenase pathway!
Primaquine reduces lots of free radicals (h202), not enough NADPH so the system can’t cope and RBCs can be killed by harmful molecules
Control of enzyme activity
1) Inhibition - often serine proteases
2) Feedback regulation
3) Covalent modification - phosphorylation used, often added to Ser or Thr
4) Proteolytic activation
What odo serpins inhibit
Serine proteases
What does trypsin cleave?
Cleaves the C terminal to lysine and arginine, prefers +ve charges, pancreatic trypsin inhibitors stop it
What does elastase do?
Elastase cleaves the C terminal to glycine and alanine!
Inhibited by alpha-1-antitrypsin
Secreted by neutrophils during inflammation to destroy bacteria
Tryspinogen
An enteropeptidase in the duodenum activates it by removing amino acids 1-6, causes a conformational shape change, can then cut itself into 3 chains held together by disulphide bonds
Thrombin
Prothrombin carried by platelets to site of injury
N-terminal of thrombin has carboxyglutamates, which bind to calcium on the platelet surface
However if no Vit K, prothrombin not in close contact with Xa & Va, thrombin isn’t released, fibrin isn’t released and blood can;t clot
Fibrinopeptides
These prevent fibrinogen reactions, normally removed by thrombin
Plasmin
Plasminogen converted to Plasmin by TPA (Tissue Type Plasminogen Activator)
Plasmin digests fibrin clot to small peptides